Researchers finished the first draft of the human genome in the year 2000. Although the decreasing cost of the technology has far outpaced Moore’s Law since then, we have yet… read more
Collaborating German and Japanese scientists have studied mice lacking a gene that plays a central role in energy metabolism. Their findings? The mice maintain their normal weight, despite consuming foods high in fats…. read more
Only about two percent of the human genome contains genes. The other 98 percent has been likened to cosmology’s dark matter that fills the space between stars – there’s a lot of it, but nobody really know what it does.
If the campaign raises more than $400,000, they’ll not only complete the Arabidopsis work, but bring illumination to the already beautiful rose as well.
Scientists have made strides recently in coming up with ways to detect autism earlier in children. But a recent study suggests it might be possible to diagnose the disorder right at the moment of birth. The telltale signs, they found, can be seen by analyzing the placenta.
“I firmly believe that this is something that’s going to revolutionize our society. With this technology we have a lot of tools that can solve a lot of humanity’s problems. We’re limited only by our imagination.”
It is thought that the increase is due to more autism cases being reported which had previously gone unreported, rather than an actual rise in the incidence of autism.
Scientists have now cured diabetes – at least in a group of dogs – and they used a gene therapy to do it.
By knocking out a specific group of neurons, scientists were able to prevent mice from feeling cold. The study sheds light on how the nervous system transmits sensory information from the body to the brain and may help develop more sophisticated pain medicines.
A woman’s diet during pregnancy could determine whether or not her child will have autism, a new study suggests. Women who took supplements of folic acid, a vitamin B variant… read more
Chalk up another victory for gene therapy. A recent clinical trial has shown that gene therapy can be used to extend the lives of children with a rare brain disorder that typically proves fatal in the first few years of life.